Viera Habalová

Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes

Zbyněk Schroner, Martin Javorský, Ružena Tkáčová et al. · Diabetes Obesity and Metabolism · 2010 · 76 citations

Sulphonylurea Treatment, Metabolic Syndrome, Molecular Pharmacology +14

MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome

Martina Čižmáriková, M Wagnerová, L Schonova et al. · The Pharmacogenomics Journal · 2009 · 72 citations

Breast Oncology, Cancer Risk, Medicine +10

Cytogenetic monitoring in coke oven workers

I Kalina, P Brezáni, Dagmar Gajdošová et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 1998 · 49 citations

Coke Oven Workers, Genetic Testing, Cytogenetics +7

Glutathione S-transferase and Microsomal Epoxide Hydrolase Gene Polymorphisms and Risk of Chronic Obstructive Pulmonary Disease in Slovak Population

Jozef Židzik, Eva Slabá, Pavol Joppa et al. · Croatian Medical Journal · 2008 · 37 citations · Full text

A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes

Ivan Tkáč, Martin Javorský, Lucia Klimčáková et al. · European Journal of Clinical Pharmacology · 2014 · 20 citations

Metabolic Syndrome, Diabetes Management, Medicine +9